• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估循环 IGF-I 和 IGFBP-3 作为犬肿瘤的生物标志物。

Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs.

机构信息

Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 05029, Korea.

Department of Veterinary Pathology, Small Animal Tumor Diagnostic Center, College of Veterinary Medicine, Konkuk University, Seoul 05029, Korea.

出版信息

J Vet Sci. 2021 Nov;22(6):e77. doi: 10.4142/jvs.2021.22.e77. Epub 2021 Sep 8.

DOI:10.4142/jvs.2021.22.e77
PMID:34697923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8636663/
Abstract

BACKGROUND

Serum-based parameters are considered non-invasive biomarkers for cancer detection. In human studies, insulin-like growth factor-I and II (IGF-I and IGF-II) and insulin-like growth factor binding protein-3 (IGFBP-3) are useful as diagnostic or prognostic markers and potential therapeutic targets.

OBJECTIVES

This study examined the diagnostic utility of circulating IGF-I, IGF-II, and IGFBP-3 levels in healthy dogs and dogs with tumors.

METHODS

The serum concentrations of these biomarkers in 86 dogs with tumors were compared with those in 30 healthy dogs using an enzyme-linked immunosorbent assay (ELISA).

RESULTS

The ELISA results showed no difference between healthy dogs and dogs with tumors in the serum IGF-II concentrations. On the other hand, there was a significant difference in the circulating IGF-I and IGFBP-3 levels between healthy dogs and dogs with tumors. The concentrations of serum IGF-I (median [interquartile range], 103.4 [59.5-175] ng/mL) in dogs with epithelial tumors were higher than those (58.4 ng/mL [43.5-79.9]) in healthy dogs. Thus, the concentrations of serum IGFBP-3 (43.4 ng/mL [33.2-57.2]) in dogs with malignant mesenchymal tumors were lower than those (60.8 ng/mL [47.6-70.5]) in healthy dogs.

CONCLUSIONS

The serum IGF-I and IGFBP-3 levels can be used as diagnostic biomarkers in dogs with tumors.

摘要

背景

基于血清的参数被认为是癌症检测的非侵入性生物标志物。在人体研究中,胰岛素样生长因子-I 和 II(IGF-I 和 IGF-II)和胰岛素样生长因子结合蛋白-3(IGFBP-3)可用作诊断或预后标志物以及潜在的治疗靶点。

目的

本研究检查了循环 IGF-I、IGF-II 和 IGFBP-3 水平在健康犬和患有肿瘤的犬中的诊断效用。

方法

使用酶联免疫吸附试验(ELISA)比较了 86 只患有肿瘤的犬和 30 只健康犬的这些生物标志物的血清浓度。

结果

ELISA 结果显示,健康犬和患有肿瘤的犬之间的血清 IGF-II 浓度没有差异。另一方面,健康犬和患有肿瘤的犬之间的循环 IGF-I 和 IGFBP-3 水平存在显著差异。患有上皮肿瘤的犬的血清 IGF-I 浓度(中位数[四分位数范围],103.4 [59.5-175]ng/mL)高于健康犬(58.4ng/mL[43.5-79.9])。因此,患有恶性间充质肿瘤的犬的血清 IGFBP-3 浓度(43.4ng/mL[33.2-57.2])低于健康犬(60.8ng/mL[47.6-70.5])。

结论

血清 IGF-I 和 IGFBP-3 水平可作为犬肿瘤的诊断生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ed/8636663/78f555de24d8/jvs-22-e77-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ed/8636663/8e88512151a7/jvs-22-e77-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ed/8636663/5786e04756d9/jvs-22-e77-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ed/8636663/78f555de24d8/jvs-22-e77-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ed/8636663/8e88512151a7/jvs-22-e77-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ed/8636663/5786e04756d9/jvs-22-e77-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ed/8636663/78f555de24d8/jvs-22-e77-g003.jpg

相似文献

1
Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs.评估循环 IGF-I 和 IGFBP-3 作为犬肿瘤的生物标志物。
J Vet Sci. 2021 Nov;22(6):e77. doi: 10.4142/jvs.2021.22.e77. Epub 2021 Sep 8.
2
Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer.血清胰岛素样生长因子-1(IGF-1)和胰岛素样生长因子结合蛋白-3(IGFBP-3)在乳腺癌患者中的临床意义
Tumour Biol. 2014 Sep;35(9):9303-9. doi: 10.1007/s13277-014-2224-2. Epub 2014 Jun 19.
3
Nutritional modulation of canine insulin-like growth factors and their binding proteins.犬胰岛素样生长因子及其结合蛋白的营养调节
J Endocrinol. 1998 Jul;158(1):77-85. doi: 10.1677/joe.0.1580077.
4
Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.绝经后妇女良性和恶性上皮性卵巢肿瘤中的血清胰岛素样生长因子(IGF)-I、IGF结合蛋白(IGFBP)-3、瘦素浓度及胰岛素抵抗
Gynecol Endocrinol. 2008 Mar;24(3):117-21. doi: 10.1080/09513590801895559.
5
Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer.血清胰岛素样生长因子-1(IGF-1)和胰岛素样生长因子结合蛋白-3(IGFBP-3)在上皮性卵巢癌患者中的临床意义
Tumour Biol. 2014 Apr;35(4):3125-32. doi: 10.1007/s13277-013-1405-8. Epub 2013 Nov 20.
6
Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.正常月经周期中胰岛素样生长因子I(IGF-I)、IGF-II以及IGF结合蛋白-1和-3的血清及卵泡液水平。
J Clin Endocrinol Metab. 1996 Mar;81(3):1224-31. doi: 10.1210/jcem.81.3.8772603.
7
Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors.卵巢肿瘤患者血清中的胰岛素样生长因子(IGF)和IGF结合蛋白(IGFBP)
Bull Exp Biol Med. 2016 Apr;160(6):814-6. doi: 10.1007/s10517-016-3317-2. Epub 2016 May 10.
8
Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia.局部性、转移性前列腺癌及良性前列腺增生症患者血清胰岛素样生长因子-I和胰岛素样生长因子结合蛋白-3的研究
Urol Int. 2004;72(1):62-5. doi: 10.1159/000075275.
9
Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.1型和2型糖尿病患者血清胰岛素样生长因子系统成分水平及其与骨代谢的关系。
J Endocrinol. 1998 Nov;159(2):297-306. doi: 10.1677/joe.0.1590297.
10
Levels of insulin-like growth factor I (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrence.术后连续血清样本中胰岛素样生长因子I(IGF-I)、IGF结合蛋白2和3的水平与前列腺癌复发风险
Urology. 2001 Mar;57(3):471-5. doi: 10.1016/s0090-4295(00)01003-7.

本文引用的文献

1
Insulin-Like Growth Factor Binding Protein-3 Exerts Its Anti-Metastatic Effect in Aerodigestive Tract Cancers by Disrupting the Protein Stability of Vimentin.胰岛素样生长因子结合蛋白-3通过破坏波形蛋白的蛋白质稳定性在气消化道癌症中发挥其抗转移作用。
Cancers (Basel). 2021 Mar 2;13(5):1041. doi: 10.3390/cancers13051041.
2
Clinical significance of serum IGFBP-3 in colorectal cancer.血清 IGFBP-3 在结直肠癌中的临床意义。
J Clin Lab Anal. 2019 Jul;33(6):e22912. doi: 10.1002/jcla.22912. Epub 2019 Jun 19.
3
26S proteasome and insulin-like growth factor-1 in serum of dogs suffering from malignant tumors.
患有恶性肿瘤犬血清中的26S蛋白酶体和胰岛素样生长因子-1
Can J Vet Res. 2018 Apr;82(2):115-123.
4
Preliminary investigation of blood concentrations of insulin-like growth factor, insulin, lactate and β-hydroxybutyrate in dogs with lymphoma as compared with matched controls.与配对对照犬相比,淋巴瘤犬胰岛素样生长因子、胰岛素、乳酸盐和β-羟基丁酸盐血药浓度的初步研究。
Vet Comp Oncol. 2018 Jun;16(2):262-267. doi: 10.1111/vco.12376. Epub 2017 Dec 4.
5
IGFBP, a novel target of lung cancer?胰岛素样生长因子结合蛋白,肺癌的新靶点?
Clin Chim Acta. 2017 Mar;466:172-177. doi: 10.1016/j.cca.2017.01.017. Epub 2017 Jan 17.
6
Insulin-Like Growth Factor-1 and Selected Insulin-Like Growth Factor Binding Protein Concentrations during an Ultramarathon Sled Dog Race.超级马拉松雪橇犬比赛期间的胰岛素样生长因子-1及选定的胰岛素样生长因子结合蛋白浓度
ScientificWorldJournal. 2016;2016:5686372. doi: 10.1155/2016/5686372. Epub 2016 Sep 5.
7
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.结合基于抗体和基于液相色谱-串联质谱的蛋白质组学技术鉴定IGFBP2和IGFBP3作为早期胰腺癌中CA19-9的代偿生物标志物
PLoS One. 2016 Aug 31;11(8):e0161009. doi: 10.1371/journal.pone.0161009. eCollection 2016.
8
Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer.血清胰岛素样生长因子-1(IGF-1)和胰岛素样生长因子结合蛋白-3(IGFBP-3)水平作为肺癌患者的临床标志物
Biomed Rep. 2016 May;4(5):609-614. doi: 10.3892/br.2016.629. Epub 2016 Mar 9.
9
The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.犬作为胰岛素样生长因子1型受体过表达乳腺癌的自然发生模型:一项观察性队列研究。
BMC Cancer. 2015 Oct 8;15:664. doi: 10.1186/s12885-015-1670-6.
10
Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.胰岛素样生长因子-1受体表达增加与犬肢体骨肉瘤较差的生存率相关。
Vet J. 2015 Aug;205(2):272-80. doi: 10.1016/j.tvjl.2014.09.005. Epub 2014 Sep 10.